Ondansetron Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 4 mg, 8 mg
Reference Brands: Zofran(US & EU)
Category:
Medical Aid
Ondansetron tablets are 5-HT3 receptor antagonists that block serotonin receptors in the gastrointestinal tract and brain, preventing nausea and vomiting. They are commonly used during chemotherapy, radiation, or postoperative care, providing effective relief from nausea, improving patient comfort, and preventing dehydration and fatigue associated with vomiting.
Ondansetron tablets is available in Tablet
and strengths such as 4 mg, 8 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ondansetron tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ondansetron tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ondansetron tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, Zofran (by GlaxoSmithKline) is a widely used branded product, while in the EU, ondansetron is available as both branded and generic formulations. Regulatory approval involves rigorous clinical and safety evaluations, and detailed dossiers ensure product quality. For more information on licensing, approved dossiers, and regulatory requirements for ondansetron tablets, visit Pharmatradz. Stay informed on the latest approval processes and market access regulations for ondansetron worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing